NYSE · Healthcare · Earnings
Next scheduled report, last quarterly EPS, consensus estimates, and TECHi commentary going into LLY's next print.
Earnings desk view
Beat/miss history and the last fiscal-year recap for Eli Lilly & Co. surface here once a unified provider exposes per-quarter EPS surprise data. EPS + P/E above are pulled live from the unified fundamentals snapshot. For real-time commentary on LLY's next print, the news archive tracks every editorial reaction to earnings reports.
Frequently asked
Eli Lilly & Co. reports quarterly. Track the latest scheduled date and consensus estimate on TECHi's LLY earnings page — updated whenever the company confirms the quarterly call.
Eli Lilly & Co.'s trailing earnings per share is approximately $28.17 based on the most recent fundamentals snapshot.
Eli Lilly & Co. trades at a P/E ratio of approximately 34.3x trailing earnings.
TECHi's LLY earnings page covers the next scheduled report, the last several quarters of beats and misses, and editorial commentary tied to each release.
Beat / miss commentary for the most recent Eli Lilly & Co. quarter is published on the TECHi LLY earnings page. Subscribe to the markets newsletter for the morning brief on every print.